search for




 

Case Report
Septic Arthritis and Infective Endocarditis in an Adolescent Hemophilia B Patient with an Inhibitor and a Central Venous Access Device
Clin Pediatr Hematol Oncol 2018;25:61-5.
Published online April 30, 2018
© 2018 Korean Society of Pediatric Hematology-Oncology and Korean Society for Pediatric Neuro-Oncology

Jisu Kim, M.D., Young Shil Park, M.D., Ph.D

Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea
Correspondence to: Young Shil Park
Department of Pediatrics, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea
Tel: +82-2-440-6133 Fax: +82-2-440-7175 E-mail: pysmd@khnmc.or.kr
Received March 25, 2018; Revised April 5, 2018; Accepted April 15, 2018.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Central venous access devices (CVAD) provide hemophilic patients, particularly children, with prolonged reliable venous access to promote routine factor replacement therapy. However, one of the significant complications of CVAD use is infection. We report the case of a severe hemophilia B patient with an inhibitor who developed septic arthritis and infective endocarditis associated with methicillin-resistant Staphylococcus aureus infection originating from a CVAD. Our patient had an underlying condition of congenital heart disease, one of the risk factors for infective endocarditis. Unfortunately, the antibiotic therapy did not have a significant effect. An echocardiogram revealed vegetation on the right ventricular moderate band and surgery was determined to be the best course of action. Septic arthritis and endocarditis rarely occur in hemophilia patients, however, they must be taken into account in hemophiliacs with continuing bacteremia.
Keywords: Central venous access devices, Hemophilia B, Ventricular septal defect, Infective endocarditis, Septic arthritis
References
  1. De Rueda B, Santa Catalina S, Lucia F, García de la Calzada D, Aguilar C. A new case of bacterial endocarditis in a child with severe haemophilia A carrying a central venous access device. Haemophilia 2015;21:e251-3.
    Pubmed CrossRef
  2. Hothi DK, Kelsall W, Baglin T, Williams DM. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters. Haemophilia 2001;7:507-10.
    Pubmed CrossRef
  3. Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000;6:66-70.
    Pubmed CrossRef
  4. Li CH, Ou Y, Lee AC, So KT. Septic arthritis in hemophilia with central venous catheter: a case report. Pediatr Hematol Oncol 2000;17:187-9.
    Pubmed CrossRef
  5. Scott JP, Flood VH. Hereditary clotting factor deficiencies. In: Kliegman RM, Stanton BF, St Geme JW, Schor N, editors, Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier, 2016;2384-8.
  6. Ljung R. The risk associated with indwelling catheters in children with haemophilia. Br J Haematol 2007;138:580-6.
    Pubmed CrossRef
  7. Tarantino MD, Lail A, Donfield SM, et al. Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia 2003;9: 588-92.
    Pubmed CrossRef
  8. Vepsäläinen K, Lassila R, Arola M, et al. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland. Haemophilia 2015;21:747-53.
    CrossRef
  9. Titapiwatanakun R, Pruthi RK, Schmidt K, Slaby JA, Rodriguez V. Bacterial endocarditis and septic arthritis in a patient with severe hemophilia A: a case report. J Pediatr Hematol Oncol 2009;31:344-5.
    Pubmed CrossRef
  10. O'Brien SE. Infective endocarditis in children. Waltham, MA: UpToDate, Inc., 2017. (Accessed March 6, 2018, at https:// www.uptodate.com/contents/infective-endocarditis-in-children)
  11. Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr 2011;170:1111-27.
    Pubmed CrossRef
  12. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
    Pubmed CrossRef
  13. Gilbert MS, Aledort LM, Seremetis S, Needleman B, Oloumi G, Forster A. Long term evaluation of septic arthritis in hemophilic patients. Clin Orthop Relat Res 1996;328:54-9.
    CrossRef
  14. Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am 2005;87:85-91.
    Pubmed CrossRef
  15. Ashrani AA, Key NS, Soucie JM, et al. Septic arthritis in males with haemophilia. Haemophilia 2008;14:494-503.
    Pubmed KoreaMed CrossRef


April 2018, 25 (1)
Full Text PDF
Citation
Send to a friend
Twitter
Facebook

Cited By Articles
  • CrossRef (0)

Author ORCID Information
  • Young Shil Park